📰 Integrated Summary News
Integrated Summary News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Integrated Summary. Real-time updates on events, politics, business and more.
June 8, 2023
Injectafer is an intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency
June 6, 2023
Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, have announced that the U.S. Food and Drug Administration (FDA) approved INJECTAFER (ferric carboxymaltose injection) for the treatment of iron deficiency in adult patients with heart failure categorized as New York Heart Association class II/III to improve exercise capacity. The company reported that with this approval, INJECTAFER is now the first and only intravenous (IV) iron replacement therapy indicated for ad...
June 5, 2023
INJECTAFER is now the first and only intravenous iron replacement therapy indicated for adult patients with heart failure who have iron deficiency ... | June 5, 2023
September 10, 2022
Learn how the clinical trial design and the statistical foundation of the special protocol assessment (SPA), which helped drive the SPA to...
May 26, 2021
Mansfield, MA (PRWEB) May 26, 2021 -- Mansfield, MA, May 26, 2021 — eClinical Solutions LLC, a global provider of cloud-based enterprise software and
May 25, 2021
Toronto, ON (PRWEB) May 25, 2021 -- Clinical development has more partnerships and collaborations than ever before with many companies acquiring assets from